                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
       UNIVERSITY OF VIRGINIA PATENT FOUNDATION, d/b/a UNIVERSITY 
       OF VIRGINIA LICENSING  & VENTURES GROUP
 
<120>  ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d 
       AND USE THEREOF

<130>  719313

<150>  US 61/924,967
<151>  2014-01-08

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  1

Gly Tyr Thr Phe Thr Ser Tyr Tyr 
1               5               


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  2

Ile Tyr Pro Gly Asn Gly Asp Thr 
1               5               


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  3

Ala Lys Gly Phe Asp 
1               5   


<210>  4
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  4

Ala Lys Tyr Gly Ser Gly 
1               5       


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  5

Gln Ser Leu Val Tyr Ser Asn Gly Asn Thr Tyr 
1               5                   10      


<210>  6
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  6

Lys Val Ser 
1           


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  7

Ser Gln Ser Thr His Val Pro Tyr Thr 
1               5                   


<210>  8
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  8

Gln Ala Tyr Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Lys Gln Thr Pro Arg Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Ala Ile Tyr Pro Gly Asn Gly Asp Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Lys Gly Phe Asp Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser 
            100                 105                 110         


Ser 
    


<210>  9
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  9

Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys Ser Gln Ser 
                85                  90                  95      


Thr His Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210>  10
<211>  114
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  10

Gln Ala Tyr Leu Gln Gln Ser Gly Ala Glu Leu Val Arg Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Met Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr 
            20                  25                  30          


Tyr Met His Trp Val Lys Gln Thr Pro Arg Gln Gly Leu Glu Trp Ile 
        35                  40                  45              


Gly Ala Ile Tyr Pro Gly Asn Gly Asp Thr Ser Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Gly Lys Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Gln Leu Ser Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Lys Tyr Gly Ser Gly Tyr Trp Gly Gln Gly Thr Thr Val Thr Val 
            100                 105                 110         


Ser Ser 
        


<210>  11
<211>  113
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  11

Asp Val Val Met Thr Gln Thr Pro Leu Ser Leu Pro Val Ser Leu Gly 
1               5                   10                  15      


Asp Gln Ala Ser Ile Ser Cys Arg Ser Ser Gln Ser Leu Val Tyr Ser 
            20                  25                  30          


Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gln Ser 
        35                  40                  45              


Pro Lys Leu Leu Ile Tyr Lys Val Ser Asn Arg Phe Ser Gly Val Pro 
    50                  55                  60                  


Asp Arg Phe Ser Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile 
65                  70                  75                  80  


Ser Arg Val Glu Ala Glu Asp Leu Gly Val Tyr Phe Cys Ser Gln Ser 
                85                  90                  95      


Thr His Val Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105                 110         


Arg 
    


<210>  12
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  12
caggcatatc tgcagcagtc cggggctgaa ctggtgcggc caggggcaag cgtcaaaatg       60

tcatgtaaag caagcggcta tactttcaca tcttactata tgcactgggt gaaacagact      120

ccacgacagg gactggagtg gatcggagca atctaccctg gcaacgggga caccagctat      180

aatcagaagt tcaaagggaa ggccaccctg acagtggata agagcagcag cactgcttac      240

atgcagctga gttcactgac cagcgaagac tccgccgtct atttttgcgc caaggggttt      300

gactactggg gacaggggac taccgtgacc gtctcctca                             339


<210>  13
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  13
gatgtggtca tgactcagac ccccctgtcc ctgccagtgt ccctgggcga tcaggcttct       60

atcagttgcc gctcctctca gtccctggtg tacagcaacg gcaataccta cctgcactgg      120

tatctgcaga agcccgggca gtcccctaag ctgctgatct ataaagtgag taaccggttc      180

tcaggagtcc cagaccggtt cagcggatcc ggatctggaa ccgatttcac actgaaaatt      240

agtagggtgg aggccgaaga cctgggcgtc tacttttgtt cacagagcac ccacgtcccc      300

tacaccttcg gcggaggcac taaactggaa atcaagcgt                             339


<210>  14
<211>  342
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  14
caggcatatc tgcagcagtc cggggctgaa ctggtgcggc caggggcaag cgtcaaaatg       60

tcatgtaaag caagcggcta tactttcaca tcttactata tgcactgggt gaaacagact      120

ccacgacagg gactggagtg gatcggagca atctaccctg gcaacgggga caccagctat      180

aatcagaagt tcaaagggaa ggccaccctg acagtggata agagcagcag cactgcttac      240

atgcagctga gttcactgac cagcgaagac tccgccgtct atttttgcgc caagtacggt      300

agtggctact ggggacaggg gactaccgtg accgtctcct ca                         342


<210>  15
<211>  339
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic

<400>  15
gatgtggtca tgactcagac ccccctgtcc ctgccagtgt ccctgggcga tcaggcttct       60

atcagttgcc gctcctctca gtccctggtg tacagcaacg gcaataccta cctgcactgg      120

tatctgcaga agcccgggca gtcccctaag ctgctgatct ataaagtgag taaccggttc      180

tcaggagtcc cagaccggtt cagcggatcc ggatctggaa ccgatttcac actgaaaatt      240

agtagggtgg aggccgaaga cctgggcgtc tacttttgtt cacagagcac ccacgtcccc      300

tacaccttcg gcggaggcac taaactggaa atcaagcgt                             339


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic (C3d Epitope 3)

<400>  16

Lys Asp Ala Pro Asp His Gln Glu Leu Asn Leu Asp Val Ser Leu Gln 
1               5                   10                  15      


Leu 
    


<210>  17
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic (C3d Epitope 1)

<400>  17

Pro Asp Gly Val Phe Gln Glu Asp Ala Pro Val Ile His Gln Glu Met 
1               5                   10                  15      


Ile Gly Gly Leu 
            20  


<210>  18
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic (C3d Epitope 2)

<400>  18

Lys Asp Ile Cys Glu Glu Gln Val Asn Ser Leu Pro Asn Ser Leu Pro 
1               5                   10                  15      


Gly Ser Ile Thr Lys Ala Gly Asp Phe Leu Glu Asp Phe Leu Glu Ala 
            20                  25                  30          


Asn 
    


<210>  19
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic (Blocking Peptide)

<400>  19

Gln Tyr Gln Lys Asp Ala Pro Asp His Gln Glu Leu Asn Leu Asp Val 
1               5                   10                  15      


Ser Leu Gln Leu Pro Ser Arg 
            20              


<210>  20
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic (Scrambled Peptide)

<400>  20

Leu Gln Pro Gln Asn Asp Val Arg Asp His Ser Pro Tyr Glu Leu Gln 
1               5                   10                  15      


Ser Leu Ala Asp Leu Lys Gln 
            20              


